UCSF

Tagged: AIDS (Acquired Immunodeficiency Syndrome)

Ruth Greenblatt, MD

Professor

My research focuses on HIV, AIDS virus, infections among women, and pharmacology of antiretroviral drugs in women. We have developed novel measures of long term exposure to these medications, which must be taken by HIV patients for long periods of time to control viral replication and to prevent...

New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:

New drug targeted for Kaposi’s sarcoma

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease.

Clinical pharmacists specialize in AIDS

From the time the antiretroviral therapy AZT was introduced in the 1980s to treat AIDS, the drug demanded close patient monitoring to be effective. AZT had many side effects and strict requirements for how and when to take it. Misuse of the drug could lead to viral resistance.